http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Helicobacter pylori 이차 제균에서 Levofloxacin 포함 삼제요법의 효과
정해선 ( Hae Sun Jung ),심기남 ( Ki Nam Shim ),백수정 ( Su Jung Baik ),나윤주 ( Youn Ju Na ),강민정 ( Min Jung Kang ),정지민 ( Ji Min Jung ),하창윤 ( Chang Yoon Ha ),정성애 ( Sung Ae Jung ),유권 ( Kwon Yoo ) 대한소화기학회 2008 대한소화기학회지 Vol.51 No.5
Background/Aims: Bismuth-based quadruple therapy for second-line eradication treatment achieves the eradication rate ranging from 70% to 81% due to antimicrobial resistance and poor compliance. The aim of this study was to compare the eradication rate of levofloxacin-based triple therapy with that of bismuth-based quadruple therapy in second-line Helicobacter pylori (H. pylori) eradication therapy. Methods: Seventy-six outpatients with persistent H. pylori infection after first-line triple therapy were enrolled in this prospective randomized trial. The subjects were randomized to receive levofloxacin 300 mg, amoxicillin 1 g, and pantoprazole 20 mg, given twice daily for 7 days (LAP group), or metronidazole 500 mg twice, tetracycline 500 mg four times, and pantoprazole 20 mg twice, bismuth subcitrate 600 mg twice daily for 7 days (MTPB group). Eradication was confirmed with 13C-urea breath test or rapid urease test 4 weeks after the cessation of therapy. Results: Among Seventy-six patients initially included, eleven were lost during follow-up. The eradication rates, expressed as intention to treat (ITT) and per protocol (PP) analyses, were 51.6% and 53.3% in the LAP group, and 48.9% and 62.9% in the MTPB group, respectively. There was no significant difference in H. pylori eradication rates between the two groups (p=0.815 by ITT, p=0.437 by PP). LAP regimen was better tolerated than MTPB regimen with lower incidence of side effects (10.0% versus 31.4%, p=0.03). Conclusions: H. pylori eradication rates of levofloxacin-based triple therapy and bismuth-based quadruple therapy were not significantly different in second-line H. pylori eradication therapy, and low incidence of side effects was observed in levofloxacin-based triple therapy. (Korean J Gastroenterol 2008;51:285-290)
『조선표류일기』를 통해 본 19세기 초 조선 선비와 일본 무사의 시문 교류
정해선(Jung, Hae sun),이근우(Rhee, Kun woo) 동북아시아문화학회 2021 동북아 문화연구 Vol.1 No.68
There was a unique culture of exchanging Chinese poems in traditional East Asian societies. They exchanged Chinese poems not only among individuals in the same country, but also among individuals in other countries. However, Chinese poems exchanged between people from other countries were often made on a formal basis between the diplomatic envoys and their counterparts. However, the Joseon Drift Diary contains Chinese poems that a Japanese samurai, who had drifted by accident, shared with Joseon officials and scholars. An important feature of this data is that there are many Chinese poems that express extremely personal feelings. Although Joseon and Japan had different countries, they were able to write Chinese characters in common, so they were able to exchange their opinions, exchange Chinese poems, and communicate with each other. Japanese samurai and Joseon people recognized each other as people of the same culture who shared the same text. The poems they exchanged show Confucian and Taoist sentiments. On the other hand, however, they were wary of each other and caused conflicts. The Joseon people refused to teach the Japanese the sea route or the geographical names due to the Japanese Invasion of Korea in 1592, and the Japanese samurai were angry at the contents of the Chinese poem, which Japan regarded as a descendant of Taebaek. Through the Joseon Drift Diary, a Japanese samurai named Yashuda was excellent enough to give a review of Chinese poems by the Joseon people, and Park Ki-soo, president of Dongnae, also highly praised the poems of Yasuda at the time. It is necessary to study how the mid or low level samurai in Japan came to have such a Chinese wring ability.
정해선 ( Hae Sun Jung ),심기남 ( Ki Nam Shim ),정지민 ( Ji Min Jung ),강민정 ( Min Jung Kang ),나윤주 ( Youn Ju Na ),정성애 ( Sung Ae Jung ),유권 ( Kwon Yoo ) 대한장연구학회 2009 Intestinal Research Vol.7 No.2
Pylephlebitis is defined as septic thrombophlebitis of the portal vein or one of its tributaries. Pylephlebitis is an uncommon and often fatal complication of intra-abdominal infections, such as diverticulitis and appendicitis. The most common bacteria isolated from patients with pylephlebitis are Escherichia coli and Bacteroides fragilis. The overall mortality rate is 32%. We describe a case of septic thrombophlebitis of the main portal vein and inferior mesenteric vein successfully treated with broad-spectrum antibiotics and anticoagulants. The early diagnosis and treatment with the timely administration of antibiotics is most important for pylephlebitis. (Intest Res 2009;7:105-109)
정해선 ( Hae Sun Jung ),심기남 ( Ki Nam Shim ),강민정 ( Min Jung Kang ),백수정 ( Su Jung Baik ),유금혜 ( Kum Hei Ryu ),정성애 ( Sung Ae Jung ),유권 ( Kwon Yoo ),민석기 ( Seog Ki Min ) 대한장연구학회 2007 Intestinal Research Vol.5 No.2
Crohn’s disease is a chronic, transmural and inflammatory disease of the gastrointestinal tract. Intraabdominalabscesses and fistulas are common complications in Crohn’s disease. However, the presence of a psoas abscess and enterocutaneous fistula in Crohn’s disease is very rare. The incidence of a psoas abscess is 0.4-4.3% and the incidence of an enterocutaneous fistula is 15-25%. Moreover, as a psoas abscess presents as a flexion contracture of the sacroiliac joint, it is apt to be misdiagnosed as arthritis, one of the common extraintestinal manifestations of Crohn’s disease. We describe here a case of a 26-year-old female who presented with pain and flexion contracture of the right sacroiliac joint. The patient was diagnosed with a psoas abscess and an enterocutaneous fistula as complications of Crohn’s disease. (Intest Res 2007;5:188-191)
소화성 궤양 치료에서 Helicobacter pylori 제균 삼제 요법과 추가적인 위산분비 억제치료의 역할
정지민 ( Ji Min Jung ),심기남 ( Ki Nam Shim ),오희정 ( Hee Jung Oh ),나윤주 ( Youn Ju Na ),정해선 ( Hae Sun Jung ),정성애 ( Sung Ae Jung ),유권 ( Kwon Yoo ) 대한소화기학회 2008 대한소화기학회지 Vol.51 No.1
목적: 최근 Helicobacter pylori에 감염된 소화성 궤양에서 H. pylori만 제균하여도 궤양이 치유되고, 추가적인 위산분비 억제제의 투여가 필요 없다는 보고가 있으나, 국내 연구는 드물다. 이번 연구에서는 전향적으로 소화성 궤양 치료효과와 관련하여 H. pylori 제균 전, 후의 위산분비 억제 치료의 유용성에 대해 연구하였다. 대상 및 방법: 2004년 5월부터 2005년 11월까지 상부위장관내시경검사에서 5 mm 크기 이상의 활동 위궤양 또는 십이지장궤양으로 진단된 환자 중, H. pylori 감염이 증명된 38명의 환자를 대상으로 전향적인 연구를 시행하였고, 28명의 환자가 연구를 완료하였다. 대상 환자들은 진단 시 H. pylori 제균치료 후 3주간 omeprazole 20 mg을 하루 한 번씩 복용하는 추가치료를 시행한 군(A군) 14명과, H. pylori 제균치료만 시행한 군(B군) 12명, omeprazole 20 mg을 하루 한 번씩 3주간 복용한 후에 H. pylori 제균치료를 한 군(C군) 12명으로 무작위 배정되었다. 제균치료 4-8주 후에 내시경 검사를 시행하였으며 H. pylori 제균 여부를 확인하기 위해서 신속 요소분해효소 검사와 조직검사를 시행하였고, 제균율, 증상 점수, 궤양의 크기, 내시경적인 궤양 치유율을 비교하고 분석하였다. 결과: 연구에 참여한 28명의 환자 중 24명이 제균에 성공하여 전체 환자의 제균율은 85.7%이었으며, A군이 87.5%, B군이 80.0%, C군이 90.0%로 세 군 간에 제균율 차이는 없었다 (p=0.80). 궤양 치유율은 A군이 100%, B군이 70%, C군이 90%로 세 군 간의 의미있는 차이는 없었다(p=0.20). 치료 전, 후의 증상 점수의 차이는 A군에서 1.8±1.2점, B군에서 1.5±1.1점, C군에서 2.3±1.1점으로 각 군 간에 의미있는 증상 점수의 차이는 없었으나(p=0.21), C군에서 증상 점수 차이가 큰 경향을 보였다. 결론: 소화성 궤양 치유에서 H. pylori 제균 전, 후에 PPI로 위산분비 억제 치료를 하는 것은 H. pylori의 제균율이나 궤양의 치유율에는 영향을 주지 못한다. 따라서, H. pylori의 제균치료만으로도 궤양 치유는 충분할 것으로 생각한다. 그러나 대상 환자 수가 작고 단일 기관에 국한된 연구이므로 더 많은 환자를 대상으로 한 연구가 필요하다. Background/Aims: It is not clear whether the anti-secretory therapy should be continued for symptomatic relief and ulcer healing before or after the eradication of H. pylori in patients with peptic ulcer disease. The aim of this study was to evaluate the effectiveness of additional anti-secretory therapy before or after H. pylori eradication in peptic ulcer disease. Methods: Thirty eight patients with H. pylori-positive active peptic ulcer were included. Patients were randomly allocated into 3 groups; standard 1-week triple therapy followed by omeprazole (20 mg, qd) for 3 weeks (group A), standard 1-week triple therapy only (group B), and omeprazole (20 mg, qd) for 3 weeks followed by 1-week triple therapy (group C). Endoscopy with the rapid urease test and histology for H. pylori was performed 4-8 weeks after the completion of treatment. The symptom was scored by a visual analog scale. Results: Of the 38 patients, 10 were excluded from the per-protocol analysis of this study. The H. pylori eradication rates were 87.5% (group A), 80.0% (group B) and 90.0% (group C) respectively. The peptic ulcer healing rates were 100% in group A, 70.0% in group B, and 90.0% in group C. There was no difference in H. pylori eradication rates and ulcer healing rates among three groups (p>0.05). Symptom score differences between pre-treatment and post-treatment group were not significantly different (p>0.05). Conclusions: The standard one week triple therapy with or without 3-weeks anti-secretory treatment with omeprazole before or after the therapy does not affect H. pylori eradication rates, peptic ulcer healing rates, and symptom score improvement. (Korean J Gastroenterol 2008;51:11-18)
내시경 점막절제술로 치료한 바렛식도에서 발생한 고도 이형성증
하창윤 ( Chang Yoon Ha ),심기남 ( Ki Nam Shim ),강민정 ( Min Jung Kang ),정지민 ( Ji Min Jung ),나윤주 ( Youn Ju Na ),정해선 ( Hae Sun Jung ),백수정 ( Su Jung Baik ),정성애 ( Sung Ae Jung ),유권 ( Kwon Yoo ),조민선 ( Min Sun Cho 대한소화기기능성질환·운동학회 2008 Journal of Neurogastroenterology and Motility (JNM Vol.14 No.1
Esophageal adenocarcinoma develop in 0.5~0.8% of Barrett`s esophagus. Although the incidence of adenocarcinoma is low, annual endoscopic surveillance is needed because of poor outcome. Recently endoscopic mucosal resection is increasingly being used in the management of early esophageal cancer because of low morbidity and mortality rates. Herein, we report a case of high grade dysplasia arising from Barrett`s esophagus treated with endoscopic mucosal resection and brief review of literatures.